Although lower concentrations of rapamycin appeared to inhibit the activation of mTOR activation in cancer cells, higher concentrations were required to increase the protein and promoter activity of OGG1, suggesting that high concentrations of rapamycin may be required to activate other kinases, such as AMPK, in addition to blocking mTOR activity [57]. This evidence concerns the gene MTOR and cancer.